NICE Approaches to Expert Opinion Evidence in Highly Specialised Technologies: Time to Change? Evidence Assessment Group Perspective

Najmeh Moradi, Nicole O’Connor, Katie H. Thomson, Hosein Shabaninejad, Tumi Sotire, Madeleine Still, Cristina Fernandez-Garcia, Sheila A. Wallace, Oleta Williams, Luke Vale and Gurdeep S. Sagoo ()
Additional contact information
Najmeh Moradi: Newcastle University
Nicole O’Connor: Newcastle University
Katie H. Thomson: Newcastle University
Hosein Shabaninejad: Newcastle University
Tumi Sotire: Newcastle University
Madeleine Still: Newcastle University
Cristina Fernandez-Garcia: Newcastle University
Sheila A. Wallace: Newcastle University
Luke Vale: Newcastle University
Gurdeep S. Sagoo: Newcastle University

PharmacoEconomics, 2024, vol. 42, issue 9, No 1, 913-917

Date: 2024
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40273-024-01405-8 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:pharme:v:42:y:2024:i:9:d:10.1007_s40273-024-01405-8

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/40273

DOI: 10.1007/s40273-024-01405-8

Access Statistics for this article

PharmacoEconomics is currently edited by Timothy Wrightson and Christopher I. Carswell

More articles in PharmacoEconomics from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().